SCHEMBL2229720

SCHEMBL2229720

Cc1nc(-c2cccc(NC(=O)c3ccc(Cl)cc3Cl)c2)cs1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56
LMNA P02545 2/20 0.56
BRD4 O60885 1/20 0.55
TP53 P04637 1/20 0.55
NPC1 O15118 7/20 0.53
RAB9A P51151 7/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
POLB P06746 1/20 0.53
NFKB1 P19838 1/20 0.53
MAPK1 P28482 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
GAA P10253 2/20 0.53
HTT P42858 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2221594 0.88 NPC1 (0.64) MAPTCYP1A2CYP2C19LMNATP53
SCHEMBL2230480 0.87 MAPT (0.58) MAPTCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL12515816 0.83 HPSE (0.59) MAPTLMNANPC1RAB9AMEN1
SCHEMBL12519327 0.83 NPC1 (0.54) MAPTLMNANPC1RAB9AMEN1
SCHEMBL12519558 0.80 MEN1 (0.51) MAPTLMNATP53NPC1RAB9A
SCHEMBL12519402 0.79 HTT (0.66) MAPTCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL17225238 0.79 RAB9A (0.67) MAPTCYP1A2CYP2C19LMNATP53
SCHEMBL1764786 0.79 MAPT (0.70) MAPTLMNABRD4TP53NPC1
SCHEMBL2739996 0.78 MAPT (0.66) MAPTCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL12519404 0.78 HTT (0.64) MAPTCYP1A2CYP3A4CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011085261-A1 HEDGEHOG INHIBITORS SELEXAGEN THERAPEUTICS, INC. (US) 2011-07-14 WO disclosed
WO-2011085261-A1 HEDGEHOG INHIBITORS SELEXAGEN THERAPEUTICS, INC. (US) 2011-07-14 WO disclosed